UK statutory group audit of a pharmaceutical company listed on German exchange

UK Plc listed on German exchange; pharmaceutical holding company with international drug development and commercialisation focused on oncology treatments.

Audit scope and key challenges

  • Investment valuation and impairment testing
  • Group consolidation across multiple jurisdictions
  • Business combination and fair value accounting
  • Complex equity funding transactions
  • Foreign currency translation
  • Going concern assessment and liquidity analysis

Our approach

  • Impairment testing on subsidiary investments
  • Component auditor coordination
  • Business combination
  • Funding arrangements and cash flow forecast evaluation
  • Equity transaction technical accounting assessment

Audit findings and outcomes

  • Identified and recommended for resolution group structure and consolidation matters
  • Assessed investment valuations and impairment conclusions
  • Identified and recommended for resolution equity transaction adjustments
  • IFRS compliant group and related party disclosures
Country:

United Kingdom

Industry:

Digital & Technology

Services:

Audit & Assurance